McGill University
9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 7 name spellings.
8
Ending by 2030
Jun 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
- 3 terms have ended since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,608,839 | Plasma source and applications thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 7,751,602 | Systems and methods of classification utilizing intensity and spatial data In force · From the USPTO record | In force | From the USPTO record | |
| US 8,057,036 | Binocular vision assessment and/or therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 8,066,372 | Binocular vision assessment and/or therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 8,710,097 | Flavonoid Dimers and Methods of Making and Using Such In force · High confidence | In force | High confidence | |
| US 7,899,225 | Systems and methods of clinical state prediction utilizing medical image data In force · From the USPTO record | In force | From the USPTO record | |
| US 9,023,806 | Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation In force · High confidence | In force | High confidence | |
| US 8,108,758 | Stochastic decoding of LDPC codes In force · From the USPTO record | In force | From the USPTO record | |
| US 11,414,703 | Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, the causative agent of heartworm disease In force · From the USPTO record | In force | From the USPTO record | |
| US 12,391,991 | Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, the causative agent of heartworm disease In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 11: 9 patents in force now held by others · 200 lapsed for an unpaid fee · 132 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 7 abandoned · 70 no status recorded